论文部分内容阅读
目的:探讨同期经尿道切除膀胱肿瘤和前列腺治疗表浅性膀胱癌合并良性前列腺增生症的手术安全性和临床疗效。方法:1 6例表浅性膀胱癌合并良性前列腺增生症患者,先行经尿道膀胱肿瘤电切术(TURBT)切除膀胱肿瘤后同期行经尿道前列腺电切术(TURP)切除前列腺。结果:患者均顺利完成手术,无膀胱穿孔和电切综合征发生,术后随访6～36个月,平均22个月,6例发生膀胱肿瘤复发,平均复发时间14个月,复发部位均不在膀胱颈口和前列腺尿道,全部再次行TURBT。结论:同期经尿道切除膀胱肿瘤和前列腺治疗表浅性膀胱癌合并良性前列腺增生症手术安全、短期疗效确切,可适用于一部分年龄较大伴有严重的下尿路梗阻的且肿瘤分期、分级低的表浅性膀胱肿瘤患者。
Objective: To investigate the surgical safety and clinical efficacy of transurethral resection of bladder tumor and prostate in the treatment of superficial bladder cancer with benign prostatic hyperplasia (BPH). Methods: Sixteen cases of superficial bladder cancer complicated with benign prostatic hyperplasia (BPH) were treated by TURBT. TURP was performed to excise the bladder in the same period. Results: All patients underwent surgery without bladder perforation and resection syndrome. The patients were followed up for 6 to 36 months with an average of 22 months. Six patients had recurrent bladder tumor with an average recurrence of 14 months. The recurrence sites were not Bladder neck and prostatic urethra, all again TURBT. Conclusions: Transurethral resection of bladder tumor and prostate in the treatment of superficial bladder cancer with benign prostatic hyperplasia is safe and short-term curative effect. It can be applied to some patients with older lower urinary tract obstruction with staging and low grade Superficial bladder cancer patients.